(1)
Impact of Xerosis in Patients With Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional, Prospective, Pilot Study. Dermatol Pract Concept 2024, 14 (4), e2024259. https://doi.org/10.5826/dpc.1404a259.